首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1807676

細胞療法製造的全球市場:市場規模·佔有率·趨勢，按產業分析 (供給來源·各細胞類型·各適應症·各手術規模·各終端用戶·各地區)，2025～2034年的市場預測

Cell Therapy Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Source, By Cell Type, By Indication, By Scale of Operation, By End User, and By Region - Market Forecast, 2025-2034

出版日期: 2025年08月01日 | 出版商:

Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據 Polaris Market Research 的最新研究，預計到 2034 年，細胞療法製造市場規模將達到 241.8 億美元。該報告深入分析了當前的市場動態，並分析了未來的市場成長。

細胞療法製造是指用於再生醫學、腫瘤學和免疫相關疾病的自體和同種異體細胞療法的大規模生產和加工。這些製造過程遵循嚴格的監管標準，以確保細胞活力、遺傳穩定性和治療效果。

全球癌症和慢性退化性疾病的發生率不斷上升，推動了市場成長，這推動了對先進細胞免疫療法的需求。再生醫學研發支出的不斷增加，加上政府資金投入和有利的監管框架，正在進一步加速產品開發。

細胞療法製造市場：分析概述

按來源劃分，自體細胞療法將在2024年佔最大的市場佔有率。這是由於針對特定患者的療法越來越多地被採用，這些療法可以降低免疫排斥風險並改善腫瘤和罕見遺傳疾病的治療效果。

依細胞類型劃分，T細胞將佔市場主導地位。這是由於複雜治療性蛋白質的生產效率高，可確保生物製劑製造中更高的療效和安全性。

按適應症劃分，預計神經系統疾病領域將增長最快，這得益於帕金森氏症、多發性硬化症和脊髓損傷等疾病的幹細胞再生療法臨床研究的增加。

以程序規模計算，由於各治療領域的臨床試驗數量不斷增加，臨床治療領域將在2024年佔主導地位。

以最終用戶計算，預計學術和研究機構將在資金和細胞療法合作的推動下實現最快成長。

受政府和私人對再生醫學研究資金不斷增加的推動，北美在2024年主導了全球細胞療法製造市場。

受生物技術擴張和再生醫學投資的推動，亞太地區呈現穩定成長。

全球主要市場參與者包括龍沙集團 (Lonza Group AG)、Minaris Regenerative Medicine、默克集團 (Merck KGaA)、賽默飛世爾科技 (Thermo Fisher Scientific Inc.)、康泰倫特公司 (Catalent, Inc.)、Charles River Laboratories、Cell Therapies Pular Fest、Fyrapyfiler Ltd. AG)、AGC Biologics、Cellistic 和 Bio-Techne。

主要的分析結果
簡介
- 細胞療法製造市場分析:各地區 (2020～2034年)
北美
- 北美:各供給來源(2020～2034年)
- 北美:各細胞類型(2020～2034年)
- 北美:各適應症(2020～2034年)
- 北美:各手術規模(2020～2034年)
- 北美:各終端用戶(2020～2034年)
- 美國
- 加拿大
歐洲
- 歐洲:各供給來源(2020～2034年)
- 歐洲:各細胞類型(2020～2034年)
- 歐洲:各適應症(2020～2034年)
- 歐洲:各手術規模(2020～2034年)
- 歐洲:各終端用戶(2020～2034年)
- 英國
- 法國
- 德國
- 義大利
- 西班牙
- 荷蘭
- 俄羅斯
- 其他歐洲
亞太地區
- 亞太地區:各供給來源(2020～2034年)
- 亞太地區:各細胞類型(2020～2034年)
- 亞太地區:各適應症(2020～2034年)
- 亞太地區:各手術規模(2020～2034年)
- 亞太地區:各終端用戶(2020～2034年)
- 中國
- 印度
- 馬來西亞
- 日本
- 印尼
- 韓國
- 澳洲
- 其他亞太地區
中東·非洲
- 中東·非洲:各供給來源(2020～2034年)
- 中東·非洲:各細胞類型(2020～2034年)
- 中東·非洲:各適應症(2020～2034年)
- 中東·非洲:各手術規模(2020～2034年)
- 中東·非洲:各終端用戶(2020～2034年)
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 南非
- 其他中東·非洲
南美
- 南美:各供給來源(2020～2034年)
- 南美:各細胞類型(2020～2034年)
- 南美:各適應症(2020～2034年)
- 南美:各手術規模(2020～2034年)
- 南美:各終端用戶(2020～2034年)
- 墨西哥
- 巴西
- 阿根廷
- 其他南美國家

第11章競爭情形

事業擴大·企業收購的分析
- 事業擴大
- 企業收購
聯盟/合作/協定/公開

第12章企業簡介

AGC Biologics
Bayer AG
Bio-Techne
Catalent, Inc.
Cell Therapies Pty Ltd.
Cellistic
Charles River Laboratories
Fujifilm Cellular Dynamics Inc.
Lonza Group AG
Merck KGaA
Minaris Regenerative Medicine
Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: PM6118

The cell therapy manufacturing market size is expected to reach USD 24.18 billion by 2034, according to a new study by Polaris Market Research. The report "Cell Therapy Manufacturing Market Share, Size, Trends, Industry Analysis Report: By Source, By Cell Type, By Indication, By Scale of Operation, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cell therapy manufacturing refers to the large-scale production and processing of autologous and allogeneic cell-based therapies used for regenerative medicine, oncology, and immune-related disorders. These manufacturing processes are conducted under stringent regulatory standards to ensure cell viability, genetic stability, and therapeutic efficacy.

The market growth is fueled by the increasing global incidence of cancer and chronic degenerative diseases, which is driving demand for advanced cell-based immunotherapies. Rising R&D expenditure in regenerative medicine coupled with government funding and favorable regulatory frameworks is further accelerating product development.

Cell Therapy Manufacturing Market Report Highlights

Based on source, the autologous cell therapy segment accounted for the largest market share in 2024, due to the growing adoption of patient-specific therapies offering reduced risk of immune rejection and improved treatment outcomes in oncology and rare genetic disorders.

Based on cell type, the T-cell segment dominated the market, driven by its high efficiency in producing complex therapeutic proteins that ensures better efficacy and safety in biologics manufacturing

Based on indication, the neurological disorders segment is expected to witness the fastest growth, fueled by increasing clinical research in stem cell-based regenerative therapies for conditions such as Parkinson's disease, multiple sclerosis, and spinal cord injuries.

Based on scale of operation, the clinical segment held the dominant share in 2024, due to the rising number of clinical trials across various therapeutic areas.

Based on end user, the academic & research institutes is expected to witness the fastest growth, driven by funding and cell therapy collaborations.

North America dominated the global cell therapy manufacturing market in 2024, fueled by expanding government and private funding for regenerative medicine research.

Asia Pacific witnessed a steady growth, driven by biotech expansion and regenerative medicine investments.

A few global key market players include Lonza Group AG, Minaris Regenerative Medicine, Merck KGaA, Thermo Fisher Scientific Inc., Catalent, Inc., Charles River Laboratories, Cell Therapies Pty Ltd., Fujifilm Cellular Dynamics Inc., Bayer AG, AGC Biologics, Cellistic, and Bio-Techne.

Polaris Market Research has segmented the market report on the basis of source, cell type, indication, scale of operation, end user, and region:

By Source Outlook (Revenue, USD Billion, 2020-2034)

Autologous Cell Therapy

Allogeneic Cell Therapy

By Cell Type Outlook (Revenue, USD Billion, 2020-2034)

T-Cells

Stem Cells

Natural Killer (NK) Cells

Dendritic Cells

Others

By Indication (Revenue, USD Billion, 2020-2034)

Oncology

Cardiovascular Diseases

Neurological Disorders

Orthopedic & Musculoskeletal Disorders

Autoimmune Diseases

Others

By Scale of Operation (Revenue, USD Billion, 2020-2034)

Clinical

Commercial

Pre-clinical

By End User (Revenue, USD Billion, 2020-2034)

Hospitals & Specialty Clinics

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Cell Therapy Manufacturing Market Insights

4.1. Cell Therapy Manufacturing Market - Market Snapshot
4.2. Cell Therapy Manufacturing Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Global R&D Expenditure
  - 4.2.1.2. Increasing Global Cancer Cases
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Manufacturing Costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Cell Therapy Manufacturing Market Trends
4.6. Value Chain Analysis

5. Global Cell Therapy Manufacturing Market, by Source

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
5.3. Autologous Cell Therapy
- 5.3.1. Global Cell Therapy Manufacturing Market, by Autologous Cell Therapy, by Region, 2020-2034 (USD Billion)
5.4. Allogeneic Cell Therapy

6. Global Cell Therapy Manufacturing Market, by Cell Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
6.3. T-Cells
- 6.3.1. Global Cell Therapy Manufacturing Market, by T-Cells, by Region, 2020-2034 (USD Billion)
6.4. Stem Cells
- 6.4.1. Global Cell Therapy Manufacturing Market, by Stem Cells, by Region, 2020-2034 (USD Billion)
6.5. Natural Killer (NK) Cells
- 6.5.1. Global Cell Therapy Manufacturing Market, by Natural Killer (NK) Cells, by Region, 2020-2034 (USD Billion)
6.6. Dendritic Cells
- 6.6.1. Global Cell Therapy Manufacturing Market, by Dendritic Cells, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Cell Therapy Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Cell Therapy Manufacturing Market, by Indication

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
7.3. Oncology
- 7.3.1. Global Cell Therapy Manufacturing Market, by Oncology, by Region, 2020-2034 (USD Billion)
7.4. Cardiovascular Diseases
- 7.4.1. Global Cell Therapy Manufacturing Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
7.5. Neurological Disorders
- 7.5.1. Global Cell Therapy Manufacturing Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
7.6. Orthopedic & Musculoskeletal Disorders
- 7.6.1. Global Cell Therapy Manufacturing Market, by Orthopedic & Musculoskeletal Disorders, by Region, 2020-2034 (USD Billion)
7.7. Autoimmune Diseases
- 7.7.1. Global Cell Therapy Manufacturing Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
7.8. Others
- 7.8.1. Global Cell Therapy Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Cell Therapy Manufacturing Market, by Scale of Operation

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
8.3. Clinical
- 8.3.1. Global Cell Therapy Manufacturing Market, by Clinical, by Region, 2020-2034 (USD Billion)
8.4. Commercial
- 8.4.1. Global Cell Therapy Manufacturing Market, by Commercial, by Region, 2020-2034 (USD Billion)
8.5. Pre-clinical
- 8.5.1. Global Cell Therapy Manufacturing Market, by Pre-clinical, by Region, 2020-2034 (USD Billion)

9. Global Cell Therapy Manufacturing Market, by End User

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
9.3. Hospitals & Specialty Clinics
- 9.3.1. Global Cell Therapy Manufacturing Market, by Hospitals & Specialty Clinics, by Region, 2020-2034 (USD Billion)
9.4. Pharmaceutical & Biotechnology Companies
- 9.4.1. Global Cell Therapy Manufacturing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
9.5. Academic & Research Institutes
- 9.5.1. Global Cell Therapy Manufacturing Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)

10. Global Cell Therapy Manufacturing Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. Cell Therapy Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
10.3. Cell Therapy Manufacturing Market - North America
- 10.3.1. North America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
- 10.3.2. North America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
- 10.3.3. North America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
- 10.3.4. North America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
- 10.3.5. North America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.3.6. Cell Therapy Manufacturing Market - U.S.
  - 10.3.6.1. U.S.: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.3.6.2. U.S.: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.3.6.3. U.S.: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.3.6.4. U.S.: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.3.6.5. U.S.: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.3.7. Cell Therapy Manufacturing Market - Canada
  - 10.3.7.1. Canada: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.3.7.2. Canada: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.3.7.3. Canada: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.3.7.4. Canada: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.3.7.5. Canada: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
10.4. Cell Therapy Manufacturing Market - Europe
- 10.4.1. Europe: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
- 10.4.2. Europe: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
- 10.4.3. Europe: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
- 10.4.4. Europe: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
- 10.4.5. Europe: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.4.6. Cell Therapy Manufacturing Market - UK
  - 10.4.6.1. UK: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.4.6.2. UK: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.4.6.3. UK: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.4.6.4. UK: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.4.6.5. UK: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.4.7. Cell Therapy Manufacturing Market - France
  - 10.4.7.1. France: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.4.7.2. France: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.4.7.3. France: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.4.7.4. France: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.4.7.5. France: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.4.8. Cell Therapy Manufacturing Market - Germany
  - 10.4.8.1. Germany: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.4.8.2. Germany: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.4.8.3. Germany: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.4.8.4. Germany: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.4.8.5. Germany: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.4.9. Cell Therapy Manufacturing Market - Italy
  - 10.4.9.1. Italy: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.4.9.2. Italy: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.4.9.3. Italy: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.4.9.4. Italy: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.4.9.5. Italy: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.4.10. Cell Therapy Manufacturing Market - Spain
  - 10.4.10.1. Spain: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.4.10.2. Spain: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.4.10.3. Spain: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.4.10.4. Spain: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.4.10.5. Spain: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.4.11. Cell Therapy Manufacturing Market - Netherlands
  - 10.4.11.1. Netherlands: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.4.11.2. Netherlands: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.4.11.3. Netherlands: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.4.11.4. Netherlands: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.4.11.5. Netherlands: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.4.12. Cell Therapy Manufacturing Market - Russia
  - 10.4.12.1. Russia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.4.12.2. Russia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.4.12.3. Russia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.4.12.4. Russia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.4.12.5. Russia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.4.13. Cell Therapy Manufacturing Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.4.13.2. Rest of Europe: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.4.13.3. Rest of Europe: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.4.13.4. Rest of Europe: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.4.13.5. Rest of Europe: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
10.5. Cell Therapy Manufacturing Market - Asia Pacific
- 10.5.1. Asia Pacific: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.5.6. Cell Therapy Manufacturing Market - China
  - 10.5.6.1. China: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.5.6.2. China: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.5.6.3. China: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.5.6.4. China: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.5.6.5. China: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.5.7. Cell Therapy Manufacturing Market - India
  - 10.5.7.1. India: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.5.7.2. India: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.5.7.3. India: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.5.7.4. India: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.5.7.5. India: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.5.8. Cell Therapy Manufacturing Market - Malaysia
  - 10.5.8.1. Malaysia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.5.8.2. Malaysia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.5.8.3. Malaysia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.5.8.4. Malaysia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.5.8.5. Malaysia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.5.9. Cell Therapy Manufacturing Market - Japan
  - 10.5.9.1. Japan: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.5.9.2. Japan: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.5.9.3. Japan: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.5.9.4. Japan: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.5.9.5. Japan: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.5.10. Cell Therapy Manufacturing Market - Indonesia
  - 10.5.10.1. Indonesia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.5.10.2. Indonesia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.5.10.3. Indonesia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.5.10.4. Indonesia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.5.10.5. Indonesia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.5.11. Cell Therapy Manufacturing Market - South Korea
  - 10.5.11.1. South Korea: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.5.11.2. South Korea: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.5.11.3. South Korea: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.5.11.4. South Korea: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.5.11.5. South Korea: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.5.12. Cell Therapy Manufacturing Market - Australia
  - 10.5.12.1. Australia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.5.12.2. Australia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.5.12.3. Australia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.5.12.4. Australia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.5.12.5. Australia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.5.13. Cell Therapy Manufacturing Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.5.13.2. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.5.13.3. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.5.13.4. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.5.13.5. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
10.6. Cell Therapy Manufacturing Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.6.6. Cell Therapy Manufacturing Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.6.6.2. Saudi Arabia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.6.6.3. Saudi Arabia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.6.6.4. Saudi Arabia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.6.6.5. Saudi Arabia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.6.7. Cell Therapy Manufacturing Market - UAE
  - 10.6.7.1. UAE: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.6.7.2. UAE: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.6.7.3. UAE: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.6.7.4. UAE: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.6.7.5. UAE: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.6.8. Cell Therapy Manufacturing Market - Israel
  - 10.6.8.1. Israel: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.6.8.2. Israel: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.6.8.3. Israel: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.6.8.4. Israel: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.6.8.5. Israel: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.6.9. Cell Therapy Manufacturing Market - South Africa
  - 10.6.9.1. South Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.6.9.2. South Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.6.9.3. South Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.6.9.4. South Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.6.9.5. South Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.6.10. Cell Therapy Manufacturing Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.6.10.2. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.6.10.3. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.6.10.4. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.6.10.5. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
10.7. Cell Therapy Manufacturing Market - Latin America
- 10.7.1. Latin America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.7.6. Cell Therapy Manufacturing Market - Mexico
  - 10.7.6.1. Mexico: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.7.6.2. Mexico: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.7.6.3. Mexico: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.7.6.4. Mexico: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.7.6.5. Mexico: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.7.7. Cell Therapy Manufacturing Market - Brazil
  - 10.7.7.1. Brazil: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.7.7.2. Brazil: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.7.7.3. Brazil: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.7.7.4. Brazil: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.7.7.5. Brazil: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.7.8. Cell Therapy Manufacturing Market - Argentina
  - 10.7.8.1. Argentina: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.7.8.2. Argentina: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.7.8.3. Argentina: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.7.8.4. Argentina: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.7.8.5. Argentina: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
- 10.7.9. Cell Therapy Manufacturing Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  - 10.7.9.2. Rest of Latin America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  - 10.7.9.3. Rest of Latin America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  - 10.7.9.4. Rest of Latin America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  - 10.7.9.5. Rest of Latin America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. AGC Biologics
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Bayer AG
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Bio-Techne
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. Catalent, Inc.
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. Cell Therapies Pty Ltd.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Cellistic
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. Charles River Laboratories
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Fujifilm Cellular Dynamics Inc.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Lonza Group AG
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Merck KGaA
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. Minaris Regenerative Medicine
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
12.12. Thermo Fisher Scientific Inc.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development

簡介目錄圖表

List of Tables:

Table 1 Global Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 2 Global Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 3 Global Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 4 Global Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 5 Global Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 6 North America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 7 North America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 8 North America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 9 North America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 10 North America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 11 U.S.: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 12 U.S.: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 13 U.S.: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 14 U.S.: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 15 U.S.: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 16 Canada: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 17 Canada: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 18 Canada: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 19 Canada: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 20 Canada: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 21 Europe: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 22 Europe: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 23 Europe: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 24 Europe: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 25 Europe: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 26 UK: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 27 UK: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 28 UK: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 29 UK: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 30 UK: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 31 France: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 32 France: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 33 France: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 34 France: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 35 France: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 36 Germany: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 37 Germany: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 38 Germany: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 39 Germany: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 40 Germany: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 41 Italy: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 42 Italy: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 43 Italy: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 44 Italy: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 45 Italy: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 46 Spain: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 47 Spain: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 48 Spain: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 49 Spain: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 50 Spain: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 51 Netherlands: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 52 Netherlands: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 53 Netherlands: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 54 Netherlands: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 55 Netherlands: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 56 Russia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 57 Russia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 58 Russia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 59 Russia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 60 Russia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 61 Rest of Europe: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 62 Rest of Europe: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 63 Rest of Europe: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 64 Rest of Europe: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 65 Rest of Europe: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 66 Asia Pacific: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 67 Asia Pacific: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 68 Asia Pacific: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 69 Asia Pacific: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 70 Asia Pacific: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 71 China: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 72 China: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 73 China: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 74 China: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 75 China: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 76 India: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 77 India: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 78 India: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 79 India: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 80 India: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 81 Malaysia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 82 Malaysia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 83 Malaysia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 84 Malaysia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 85 Malaysia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 86 Japan: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 87 Japan: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 88 Japan: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 89 Japan: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 90 Japan: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 91 Indonesia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 92 Indonesia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 93 Indonesia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 94 Indonesia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 95 Indonesia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 96 South Korea: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 97 South Korea: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 98 South Korea: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 99 South Korea: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 100 South Korea: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 101 Australia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 102 Australia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 103 Australia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 104 Australia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 105 Australia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 106 Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 107 Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 108 Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 109 Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 110 Rest of Asia Pacific: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 111 Middle East & Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 112 Middle East & Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 113 Middle East & Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 114 Middle East & Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 115 Middle East & Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 116 Saudi Arabia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 117 Saudi Arabia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 118 Saudi Arabia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 119 Saudi Arabia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 120 Saudi Arabia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 121 UAE: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 122 UAE: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 123 UAE: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 124 UAE: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 125 UAE: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 126 Israel: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 127 Israel: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 128 Israel: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 129 Israel: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 130 Israel: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 131 South Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 132 South Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 133 South Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 134 South Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 135 South Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 136 Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 137 Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 138 Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 139 Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 140 Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 141 Latin America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 142 Latin America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 143 Latin America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 144 Latin America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 145 Latin America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 146 Mexico: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 147 Mexico: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 148 Mexico: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 149 Mexico: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 150 Mexico: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 151 Brazil: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 152 Brazil: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 153 Brazil: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 154 Brazil: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 155 Brazil: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 156 Argentina: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 157 Argentina: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 158 Argentina: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 159 Argentina: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 160 Argentina: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
Table 161 Rest of Latin America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
Table 162 Rest of Latin America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
Table 163 Rest of Latin America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
Table 164 Rest of Latin America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
Table 165 Rest of Latin America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Cell Therapy Manufacturing Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Source
Figure 7. Global Cell Therapy Manufacturing Market, by Source, 2024 & 2034 (USD Billion)
Figure 8. Market by Cell Type
Figure 9. Global Cell Therapy Manufacturing Market, by Cell Type, 2024 & 2034 (USD Billion)
Figure 10. Market by Indication
Figure 11. Global Cell Therapy Manufacturing Market, by Indication, 2024 & 2034 (USD Billion)
Figure 12. Market by Scale of Operation
Figure 13. Global Cell Therapy Manufacturing Market, by Scale of Operation, 2024 & 2034 (USD Billion)
Figure 14. Market by End User
Figure 15. Global Cell Therapy Manufacturing Market, by End User, 2024 & 2034 (USD Billion)